抗体名: Anti-Human CD317/BST2 Antibody (HM1.24)(流式抗体) 亚型: IgG1, kappa 浓度: 1 mg/ml % 是否单克隆: 是 靶点: CD317/BST2 免疫原: Mouse 宿主: Mouse 用途: 仅用于科研 保质期: 1 year 应用范围: FCM 产地: France 标记物: Unconjugate 品牌: AntibodySystem 包装规格...
PE anti-human CD317 (BST2, Tetherin) Antibody 产品类别:抗体 产品编号:348405 产品应用 :348405规格 价格库存 25tests ￥ 2142 1 立即订购 订购热线:021-34661276 收藏此商品 我要询价 上海细胞库人源细胞系 稳转细胞系 基因敲除株 基因点突变细胞株 大鼠细胞系 小鼠细胞系 其他细胞系...
上海玉博生物科技有限公司 主要致力于“anti-human CD317 PE (BST2, Clone: 26F8) 25 tests eBioscience-12-3179-41”的生产销售。多年的“anti-human CD317 PE (BST2, Clone: 26F8) 25 tests eBioscience-12-3179-41”生产与销售的经验,与各行业新老用户建立了稳定的合作
CAS号: 英文名: Anti-BST2/CD317 英文别名: Anti-BST2/CD317 中文名: Anti-BST2/CD317 中文别名: 骨髓基质干细胞抗原2抗体 CBNumber: CB55537508 分子式: 分子量: 0 MOL File: Mol file 化学性质 安全信息 用途 供应商 25 Anti-BST2/CD317化学性质 ...
ChemicalBook provide Chemical industry users with Spark UV 387 anti-mouse CD317 (BST2, PDCA-1) Antibody Boiling point Melting point,Spark UV 387 anti-mouse CD317 (BST2, PDCA-1) Antibody Density MSDS Formula Use,If You also need to Spark UV 387 anti-mouse
Interferon-伪 enhances CD317 expression and the antitumor activity of anti-CD317 monoclonal antibody in renal cell carcinoma xenograft models. Shigeto Kawai,Yumiko Azuma,Etsuko Fujii,Kou Furugaki,Shuji Ozaki,Toshio Matsumoto,Masaaki Kosaka,Hisafumi Yamada-Okabe. Canc...
The humanized monoclonal antibody (mAb) against CD317 antigen (anti-HM1.24 antibody; AHM), which is highly expressed on multiple myeloma (MM), induces antibody-dependent cellular cytotoxicity (ADCC). However, the antitumor activity of AHM in the clinical setting has not been clearly demonstrated....
在线询价 优惠:请询价 订货号:2AN5889 品牌型号:Affymetrix 25-3172-80 货期:询货期 最小订货量:1套 +- Affymetrix 联系我们 400-920-3909 微信扫一扫,手机采购 商品介绍 规格参数 包装参数 ANTI-MO CD317 927 PE-CYN7 25UG,25-3172-80,Affymetrix 相关资料正在准备中......
订货号:2NJ8777 品牌型号:Affymetrix 12-3172-82 货期:询货期 最小订货量:1套 +- Affymetrix 联系我们 400-920-3909 微信扫一扫,手机采购 商品介绍 规格参数 包装参数 ANTI-MO CD317 927 PE 100UG,12-3172-82,Affymetrix 相关资料正在准备中...
HM1.24 antigen (CD317) was originally identified as a cell surface protein that is preferentially overexpressed on multiple myeloma cells. Immunotherapy using anti-HM1.24 antibody has been performed in patients with multiple myeloma as a phase I study. We examined the expression of HM1.24 antigen ...